All Stories

  1. Comprehensive Genetic Study of a Monozygotic Triplet Discordant for Autism Spectrum Disorder
  2. An interpretable block-attention network for identifying regulatory feature interactions
  3. Genomic selection signatures in autism spectrum disorder identifies cognitive genomic tradeoff and its relevance in paradoxical phenotypes of deficits versus potentialities
  4. Epigenetic Alterations in Alzheimer’s Disease and Its Therapeutic and Dietary Interventions
  5. Genetic gateways to COVID‐19 infection: Implications for risk, severity, and outcomes
  6. Methylation Map Genes Can be Critical in Determining the Methylome of Intracranial Aneurysm Patients
  7. Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease
  8. An Immunological Perspective to Non-syndromic Sensorineural Hearing Loss
  9. Genetics of Epigenome Might Hold the Clue for Determining the Threshold of Environmental Impact
  10. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review
  11. Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism
  12. Pharmacoepigenetics of Antipsychotic Drugs
  13. Association of matrix metalloproteinase 2 and matrix metalloproteinase 9 gene polymorphism in aggressive and nonaggressive odontogenic lesions: A pilot study
  14. Understanding the role of genetic variability in LRRK2 in Indian population
  15. Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia
  16. Antipsychotic drugs can influence host epigenome
  17. Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells
  18. Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs
  19. Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy
  20. Pharmaco-Epigenomic Response of Antipsychotic Drugs In Theranostics of Schizophrenia
  21. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson’s disease patients
  22. Evaluation of salivary DNA obtained from dental prosthesis and its applicability in forensic investigations
  23. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia
  24. Erratum to: Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors
  25. Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors
  26. Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm
  27. DNA Methyl Transferase (DNMT) Gene Polymorphisms Could Be a Primary Event in Epigenetic Susceptibility to Schizophrenia
  28. Genetic Association Analysis of ATP Binding Cassette Protein Family Reveals a Novel Association of ABCB1 Genetic Variants with Epilepsy Risk, but Not with Drug-Resistance
  29. Circadian rhythm of homocysteine is hCLOCK genotype dependent
  30. Cytokine gene polymorphism (interleukin-1β +3954, Interleukin-6 [−597/−174] and tumor necrosis factor-α −308) in chronic periodontitis with and without type 2 diabetes mellitus
  31. Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy
  32. Corrigendum to “Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis” [Gene 526 (2013) 449–453]
  33. GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures
  34. Lack of association of Lysyl oxidase (LOX) gene polymorphisms with intracranial aneurysm in a south Indian population
  35. Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis
  36. Association of Cytokine Gene Polymorphisms with Oral Lichen Planus in Malayalam-Speaking Ethnicity from South India (Kerala)
  37. Association of interleukin-4 and interleukin-17F polymorphisms in periodontitis in Dravidian ethnicity
  38. Failure to find association between febrile seizures and SCN1A rs3812718 polymorphism in south Indian patients with mesial temporal lobe epilepsy and hippocampal sclerosis
  39. Antipsychotic Drug Dosage and Therapeutic Response in Schizophrenia is Influenced by ABCB1 Genotypes: A Study from a South Indian Perspective
  40. Evidence for transforming Growth Factor-Beta 3 gene polymorphism in non-syndromic cleft lip and palate patients from Indian sub-continent
  41. Is pharmacogenomics a reality? Challenges and oppurtunities for India
  42. Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective
  43. Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene?
  44. Transforming growth factor-β-1 polymorphisms are infrequent but exist at selected loci in oral submucous fibrosis
  45. Association of Single Nucleotide Gene Polymorphism at Interleukin‐1β +3954, −511, and −31 in Chronic Periodontitis and Aggressive Periodontitis in Dravidian Ethnicity
  46. Risk Factors for Aneurysmal Subarachnoid Hemorrhage in an Indian Population
  47. Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population
  48. Analysis of Genotype and Haplotype Effects of ABCB1 (MDR1) Polymorphisms in the Risk of Medically Refractory Epilepsy in an Indian Population
  49. Universal protocol for generating 100bp size standard for endless usage
  50. Role of Endothelial Nitric Oxide Synthase Gene Polymorphisms in Predicting Aneurysmal Subarachnoid Hemorrhage in South Indian Patients
  51. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population
  52. A Case‐Control Study on the Association of Human Leukocyte Antigen‐A*9 and ‐B*15 Alleles With Generalized Aggressive Periodontitis in an Indian Population
  53. A crypto‐Dravidian origin for the nontribal communities of South India based on human leukocyte antigen class I diversity
  54. Association of an Extended Haplotype of HLA Class I Alleles and Their Flanking Microsatellites with Spondyloarthropathies in South Indian Patients
  55. Lack of association of Endoglin insertion polymorphism in intracranial aneurysm in South Indian population
  56. Population dynamics of the Teak defoliator (Hyblaea puera Cramer) in Nilambur teak plantations using Randomly Amplified Gene Encoding Primers (RAGEP)
  57. HLA-A allele frequency and haplotype distribution in the dravidian tribal communities of south India
  58. HLA‐B and HLA‐C alleles and haplotypes in the Dravidian tribal populations of southern India
  59. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India
  60. Genetic variation in Asiatic lions and Indian tigers